ESR1 and breast carcinoma: Among E2 non-transcriptional signalling pathways are ERα-dependent activation of the PI3K/protein kinase B (Akt) axis [43] and ER-independent activation of maxi-K channels, both of which promote breast cancer cell growth [44].